Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter P Balingit

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Journal of Family Practice|May 4, 2022
Innumerable pulmonary nodulesBrian M Fung, Nasser Mikhail, Peter P Balingit
Academic Medicine : Journal of the Association of American Medical Colleges|June 28, 2005
Negotiating end-of-life decision making: a comparison of Japanese and U.S. residents' approachesBaback B Gabbay, Shinji Matsumura, Shiri Etzioni, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|June 8, 2012
NorLeu3-A(1-7) stimulation of diabetic foot ulcer healing: results of a randomized, parallel-group, double-blind, placebo-controlled phase 2 clinical trialPeter P Balingit, David G Armstrong, Alexander M Reyzelman, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Journal of Family Practice|May 4, 2022
Innumerable pulmonary nodulesBrian M Fung, Nasser Mikhail, Peter P Balingit
Academic Medicine : Journal of the Association of American Medical Colleges|June 28, 2005
Negotiating end-of-life decision making: a comparison of Japanese and U.S. residents' approachesBaback B Gabbay, Shinji Matsumura, Shiri Etzioni, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|June 8, 2012
NorLeu3-A(1-7) stimulation of diabetic foot ulcer healing: results of a randomized, parallel-group, double-blind, placebo-controlled phase 2 clinical trialPeter P Balingit, David G Armstrong, Alexander M Reyzelman, et al.
Pageof 1